Interferon-β treatment for relapsing multiple sclerosis

By Weinstock-Guttman Bianca   Ramanathan Murali   Zivadinov Robert  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 9, 2008-09 ,pp. : 1435-1447

Informa Healthcare

Access to resources Recommend Favorite

Neutralising antibodies to IFN-&bgr; in patients with multiple sclerosis

By Bagnato Francesca   Riva Marco   Antonelli Guido  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 8, 2006-08 ,pp. : 773-785

Informa Healthcare

Access to resources Recommend Favorite

Clinical effects and tolerability of high-dose, high-frequency recombinant interferon β-1a in patients with multiple sclerosis: maximizing therapy through long-term adherence

By Boyko Alexey N  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 4, 2010-04 ,pp. : 653-666

Informa Healthcare

Access to resources Recommend Favorite

Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients’ individual gene expression in peripheral blood

By Hecker Michael   Hartmann Christiane   Kandulski Ole   Paap Brigitte   Koczan Dirk   Thiesen Hans-Juergen   Zettl Uwe  

Molecular Neurobiology, Vol. 48, Iss. 3, 2013-12 ,pp. : 737-756

Humana Press, Inc

Access to resources Recommend Favorite

Natalizumab and the role of α₄-integrin antagonism in the treatment of multiple sclerosis

By O’Connor Paul  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 1, 2007-01 ,pp. : 123-136

Informa Healthcare

Access to resources Recommend Favorite